These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 17079309)

  • 1. Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.
    Gupta S; Leutenegger CM; Dean GA; Steckbeck JD; Cole KS; Sparger EE
    J Virol; 2007 Jan; 81(2):465-73. PubMed ID: 17079309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
    Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
    Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV.
    Maksaereekul S; Dubie RA; Shen X; Kieu H; Dean GA; Sparger EE
    Vaccine; 2009 Jun; 27(28):3754-65. PubMed ID: 19464559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif.
    Leutenegger CM; Boretti FS; Mislin CN; Flynn JN; Schroff M; Habel A; Junghans C; Koenig-Merediz SA; Sigrist B; Aubert A; Pedersen NC; Wittig B; Lutz H
    J Virol; 2000 Nov; 74(22):10447-57. PubMed ID: 11044089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression.
    Boretti FS; Leutenegger CM; Mislin C; Hofmann-Lehmann R; König S; Schroff M; Junghans C; Fehr D; Huettner SW; Habel A; Flynn JN; Aubert A; Pedersen NC; Wittig B; Lutz H
    AIDS; 2000 Aug; 14(12):1749-57. PubMed ID: 10985311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine.
    Sparger EE; Dubie RA; Shacklett BL; Cole KS; Chang WL; Luciw PA
    Virology; 2008 May; 374(2):261-72. PubMed ID: 18261756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and characterization of feline immunodeficiency virus proviral mutants that coexpress interferon gamma and green fluorescent protein.
    Gupta S; Leutenegger C; Dean G; Sparger E
    AIDS Res Hum Retroviruses; 2006 Apr; 22(4):342-9. PubMed ID: 16623638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
    Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
    AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An initial examination of the potential role of T-cell immunity in protection against feline immunodeficiency virus (FIV) infection.
    Aranyos AM; Roff SR; Pu R; Owen JL; Coleman JK; Yamamoto JK
    Vaccine; 2016 Mar; 34(12):1480-8. PubMed ID: 26802606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against feline immunodeficiency virus using replication defective proviral DNA vaccines with feline interleukin-12 and -18.
    Dunham SP; Flynn JN; Rigby MA; Macdonald J; Bruce J; Cannon C; Golder MC; Hanlon L; Harbour DA; Mackay NA; Spibey N; Jarrett O; Neil JC
    Vaccine; 2002 Feb; 20(11-12):1483-96. PubMed ID: 11858854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins.
    Leutenegger CM; Hofmann-Lehmann R; Holznagel E; Cuisinier AM; Wolfensberger C; Duquesne V; Cronier J; Allenspach K; Aubert A; Ossent P; Lutz H
    AIDS Res Hum Retroviruses; 1998 Feb; 14(3):275-83. PubMed ID: 9491919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prime-boost vaccination using DNA and whole inactivated virus vaccines provides limited protection against virulent feline immunodeficiency virus.
    Dunham SP; Bruce J; Klein D; Flynn JN; Golder MC; MacDonald S; Jarrett O; Neil JC
    Vaccine; 2006 Nov; 24(49-50):7095-108. PubMed ID: 17049683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies.
    Hosie MJ; Flynn JN; Rigby MA; Cannon C; Dunsford T; Mackay NA; Argyle D; Willett BJ; Miyazawa T; Onions DE; Jarrett O; Neil JC
    J Virol; 1998 Sep; 72(9):7310-9. PubMed ID: 9696827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
    Kusuhara H; Hohdatsu T; Okumura M; Sato K; Suzuki Y; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
    Vet Microbiol; 2005 Jul; 108(3-4):155-65. PubMed ID: 15899558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 p24 vaccine protects cats against feline immunodeficiency virus infection.
    Coleman JK; Pu R; Martin M; Sato E; Yamamoto JK
    AIDS; 2005 Sep; 19(14):1457-66. PubMed ID: 16135898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of Feline ELISpot to Evaluate the Immunogenicity of a T Cell-Based FIV MAP Vaccine.
    Sahay B; Aranyos AM; McAvoy A; Yamamoto JK
    Methods Mol Biol; 2018; 1808():197-219. PubMed ID: 29956186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of protection against feline immunodeficiency virus infection among domestic cats in New Zealand vaccinated with the Fel-O-Vax® FIV vaccine.
    Stickney A; Ghosh S; Cave NJ; Dunowska M
    Vet Microbiol; 2020 Nov; 250():108865. PubMed ID: 33045631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental vaccine protection against feline immunodeficiency virus.
    Yamamoto JK; Okuda T; Ackley CD; Louie H; Pembroke E; Zochlinski H; Munn RJ; Gardner MB
    AIDS Res Hum Retroviruses; 1991 Nov; 7(11):911-22. PubMed ID: 1662057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.
    Flynn JN; Beatty JA; Cannon CA; Stephens EB; Hosie MJ; Neil JC; Jarrett O
    AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1107-13. PubMed ID: 8554908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates.
    Pu R; Coleman J; Omori M; Arai M; Hohdatsu T; Huang C; Tanabe T; Yamamoto JK
    AIDS; 2001 Jul; 15(10):1225-37. PubMed ID: 11426067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.